(Q40935884)

25 September 2017

title

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas (English)

1 reference

evasion of host immune response

25 September 2017

main subject

1 reference

Gutierrez LS

1

1 reference

25 September 2017

Eliza M

2

1 reference

25 September 2017

Niven-Fairchild T

3

1 reference

25 September 2017

Naftolin F

4

1 reference

25 September 2017

Mor G

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Breast Cancer Research and Treatment

25 September 2017

published in

1 reference

25 September 2017

volume

54

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

245-253

1 reference

Gangliosides and antitumor immunity

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

Human Fas ligand: gene structure, chromosomal location and species specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

A vision of cell death: insights into immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

Fas ligand mediates activation-induced cell death in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

7 January 2021

Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

7 January 2021

Essential roles of the Fas ligand in the development of hepatitis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

7 January 2021

Cell-mediated immunity in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006102601215

7 January 2021

Identifiers

DOI

10.1023/A:1006102601215

1 reference

Dimensions Publication ID

25 September 2017

1046611036

0 references

1 reference